Research programme: AZM 145 - Alizyme

Drug Profile

Research programme: AZM 145 - Alizyme

Alternative Names: AZM 145

Latest Information Update: 16 Oct 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alizyme; University of Birmingham School of Medicine
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 16 Oct 2001 Discontinued-Preclinical for Diabetes mellitus in United Kingdom (PO)
  • 19 Oct 2000 Alizyme is seeking partners for the programme (
  • 29 Oct 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top